Your session is about to expire
← Back to Search
High-Intensity Interval Training for Sarcopenia
Study Summary
This trial will compare a 12-week high-intensity interval training program with a focus on cardiovascular endurance, neuromuscular function, and muscle architecture in older adults.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 65 and 95 years old.I can take care of myself without help.I have a condition like Parkinson's, had a stroke, or a traumatic brain injury.You have significant problems with memory and thinking.You have not participated in a formal strength training program in the last 6 months.
- Group 1: Total Body HIIT Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants of this trial exclusively limited to those aged twenty or older?
"The primary criteria for inclusion in this medical trial is an age range between 65 and 95 years old."
Is it feasible for applicants to join this clinical experiment at present?
"According to clinicaltrials.gov, this trial is not currently seeking participants; however, the initial posting was on November 1st 2022 and last edited September 13th 2022. Despite that this study has paused recruitment for now, there are 107 other studies actively recruiting patients at present."
What are the aims of this research endeavor?
"The primary objective of the HIIT intervention trial is to gauge changes in voluntary muscle strength (isokinetics) over time. Secondary outcomes being tracked include balance, health-related quality of life and gait speed using a variety of clinical assessments such as the SF-36 survey and 10 meter walking tests."
Who would meet the criteria for admittance into this trial?
"This research trial is taking on 60 people with sarcopenia aged between 65 and 95. Crucially, potential participants must abide by the following conditions: be within the age range of 65-95 years old, have a doctor's blessing to join in, display physical autonomy (Barthel Index), not alter their medication regimen for 30 days prior, and abstain from any form of resistance training 6 months prior to joining."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger